Positron emission tomography diagnosis of Alzheimer's disease

被引：36
|
作者：
Coleman, RE [1 ]
机构：
[1] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA
来源：
NEUROIMAGING CLINICS OF NORTH AMERICA | 2005年 / 15卷 / 04期
关键词：
D O I：
10.1016/j.nic.2005.09.007
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Positron emission tomography (PET) imaging of [18F]-2-fluoro-2-deoxy-D-glucose (FDG) is accurate in the early detection of Alzheimer's disease (AD) and in the differentiation of AD from the other causes of dementia. FDG-PET imaging is available widely and performed easily. Different patterns of abnormality with the various causes of dementia are well described. Semiquantitative methods of image interpretation are available. Medicare covers FDG-PET imaging for the narrow indication of differentiation of possible AD from frontotemporal dementia.
引用
下载
收藏
页码：837 / +
页数：11
相关论文
共 50 条
  • [41] Positron emission tomography metabolic correlates of apathy in Alzheimer disease
    Marshall, Gad A.
    Monserratt, Lorena
    Harwood, Dylan
    Mandelkern, Mark
    Cummings, Jeffrey L.
    Sultzer, David L.
    ARCHIVES OF NEUROLOGY, 2007, 64 (07) : 1015 - 1020
  • [42] Imaging the pathology of Alzheimer's disease:: amyloid-imaging with positron emission tomography
    Klunk, WE
    Engler, H
    Nordberg, A
    Bacskai, BJ
    Wang, YM
    Price, JC
    Bergström, M
    Hyman, BT
    Långström, B
    Mathis, CA
    NEUROIMAGING CLINICS OF NORTH AMERICA, 2003, 13 (04) : 781 - +
  • [43] Activation positron emission tomography demonstrates neurotrophic properties of propentofylline in Alzheimer's disease
    Mielke, R
    Ghaemi, M
    Kessler, J
    Kittner, B
    Herholz, K
    Heiss, WD
    ANNALS OF NEUROLOGY, 1996, 40 (03) : M45 - M45
  • [44] Amyloid and Tau Positron Emission Tomography Imaging in Alzheimer's Disease and Other Tauopathies
    Maschio, Cinzia
    Ni, Ruiqing
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [45] Serial positron emission tomography findings in a patient with hydrocephalic dementia and Alzheimer's disease
    Jeong, Y
    Chin, J
    Tae, WS
    Hong, SB
    Kim, SE
    Suh, YL
    Na, DL
    JOURNAL OF NEUROIMAGING, 2004, 14 (02) : 170 - 175
  • [46] Tau positron emission tomography in patients with cognitive impairment and suspected Alzheimer's disease
    Matsuda, Hiroshi
    Yamao, Tensho
    FUKUSHIMA JOURNAL OF MEDICAL SCIENCE, 2023, 69 (02) : 85 - 93
  • [47] Positron Emission Tomography in Animal Models of Alzheimer's Disease Amyloidosis: Translational Implications
    Ni, Ruiqing
    PHARMACEUTICALS, 2021, 14 (11)
  • [48] Neuronal substrates for semantic memory: A positron emission tomography study in Alzheimer's disease
    Hirono, N
    Mori, E
    Ishii, K
    Imamura, T
    Tanimukai, S
    Kazui, H
    Hashimoto, M
    Takatsuki, Y
    Kitagaki, H
    Sasaki, M
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2001, 12 (01) : 15 - 21
  • [49] Predicting cognitive decline in Alzheimer's disease using positron emission tomography.
    Nishimura, S
    Minoshima, S
    Giordani, B
    Johanns, J
    Little, RJA
    Foster, NL
    Kuhl, DE
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 96P - 96P
  • [50] Comparison of positron emission tomography and lymphangiography in the diagnosis of infradiaphragmatic Hodgkin's disease
    Valette, F.
    Querellou, S.
    Oudoux, A.
    Carlier, T.
    Dupas, B.
    Chatal, J. -F.
    Couturier, O.
    ACTA RADIOLOGICA, 2007, 48 (01) : 59 - 63
12345